Ovid (OVID) shares surge 92% after soticlestat deal with Takeda in rare epilepsy syndromes
March 03 2021 - 7:21AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
From Sep 2023 to Sep 2024